Evidence map›Paper›PMID 29727369›Full record

Trial reportCritical care medicine2018

Blue Light Enhances Bacterial Clearance and Reduces Organ Injury During Sepsis.

Anthony J Lewis, Xianghong Zhang, John E Griepentrog, Du Yuan, Richard D Collage, Paul K Waltz, Derek C Angus, Brian S Zuckerbraun, Matthew R Rosengart

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Critical care medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06626334 (Blue Light as an Anti-inflammatory and Analgesic Strategy in Thoracic Trauma), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06626334 naterminatednot on this mapstarted 2024, after this paper: background citation

Blue Light as an Anti-inflammatory and Analgesic Strategy in Thoracic Trauma: A Randomized Controlled Trial in Adults With Rib Fractures

TypeinterventionalSponsorRebecca E Kotcher, MDRan2024 to 2026Enrolled27ConditionsRib Fractures, Pain, AcuteArmsBright Blue Light, Bright Full-Spectrum (White) Light, Usual Ambient Light
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. The influence of light on Interleukin-10: A preliminary study.Brain, behavior, & immunity - health · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. New Insights Into Blue Light Phototherapy in ExperimentalFrontiers in cellular and infection microbiology · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Anthony J LewisDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA.
Xianghong ZhangDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA.
John E GriepentrogDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA.
Du YuanDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA.
Richard D CollageDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA.
Paul K WaltzDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA.
Derek C AngusDepartment of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA.
Brian S ZuckerbraunDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA.
Matthew R RosengartDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA.
University of Pittsburgh · USCentral South University · CN

Funding

TRAINING IN TRAUMA AND SEPSIS RESEARCHT32GM008516 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TIMOTHY R BILLIAR · 1994 to 2026
$9.4M
CaMK: Central Regulators of the response to Surgical SepsisR01GM082852 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROSENGART, MATTHEW RANDALL · 2009 to 2020
$3.0M
Blue light protects against ischemia induced organ injuryR01GM116929 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROSENGART, MATTHEW RANDALL · 2016 to 2019
$1.2M
NIGMS NIH HHS R01 GM082852NIGMS NIH HHS R01 GM116929NIGMS NIH HHS T32 GM008516
6 · The paper itself

Abstract

objectivesThe physiology of nearly all mammalian organisms are entrained by light and exhibit circadian rhythm. The data derived from animal studies show that light influences immunity, and these neurophysiologic pathways are maximally entrained by the blue spectrum. Here, we hypothesize that bright blue light reduces acute kidney injury by comparison with either bright red or standard, white fluorescent light in mice subjected to sepsis. To further translational relevance, we performed a pilot clinical trial of blue light therapy in human subjects with appendicitis.

designLaboratory animal research, pilot human feasibility trial.

settingUniversity basic science laboratory and tertiary care hospital. SUBJECTS: Male C57BL/6J mice, adult (> 17 yr) patients with acute appendicitis.

interventionsMice underwent cecal ligation and puncture and were randomly assigned to a 24-hour photoperiod of bright blue, bright red, or ambient white fluorescent light. Subjects with appendicitis were randomized to receive postoperatively standard care or standard care plus high-illuminance blue light. MEASUREMENTS AND MAIN

resultsExposure to bright blue light enhanced bacterial clearance from the peritoneum, reduced bacteremia and systemic inflammation, and attenuated the degree of acute kidney injury. The mechanism involved an elevation in cholinergic tone that augmented tissue expression of the nuclear orphan receptor REV-ERBα and occurred independent of alterations in melatonin or corticosterone concentrations. Clinically, exposure to blue light after appendectomy was feasible and reduced serum interleukin-6 and interleukin-10 concentrations.

conclusionsModifying the spectrum of light may offer therapeutic utility in sepsis.

Indexed as

Acute Kidney InjuryAdultAnimalsAppendicitisCytokinesFemaleHumansHydrocortisoneInflammation MediatorsMaleMiceMice, Inbred C57BLMicrobiological TechniquesMiddle AgedOrgan Dysfunction ScoresPhototherapyCytokinesHydrocortisoneInflammation Mediators

Identifiers

PMID29727369
PMCPMC6045458
OpenAlexW2802480458

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.